ASTER DM HEALTHCARE share price has zoomed 7% and is presently trading at Rs 371.2.
Meanwhile, the BSE HEALTHCARE index is at 40,562.1 (up 0.1%).
Among the top gainers in the BSE HEALTHCARE index today are Jubilant Pharmova (up 10.6%) and SYNGENE INTERNATIONAL (up 2.8%).
HIKAL CHEMIC (down 2.7%) and LAURUS LABS (down 2.0%) are among the top losers today.
Over the last one year, ASTER DM HEALTHCARE has moved up from Rs 312.5 to Rs 371.2, registering a gain of Rs 58.7 (up 18.8%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,736.5 to 40,562.1, registering a gain of 46.2% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 126.8%), SUVEN PHARMACEUTICALS (up 98.8%) and Cadila Healthcare (up 97.4%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,804.0 (up 0.1%).
The top gainers among the BSE Sensex today are Power Grid Corp. (up 3.1%) and NTPC (up 1.5%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.
In the meantime, NSE Nifty is at 24,990.6 (up 0.2%). Coal India and Power Grid Corp. are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,527.7 to 81,804.0, registering a gain of 15,276.3 points (up 23.0%).
ASTER DM HEALTHCARE net profit grew 75.3% YoY to Rs 837 million for the quarter ended June 2024, compared to a profit of Rs 477 million a year ago. Net sales rose 19.1% to Rs 10,019 million during the period as against Rs 8,412 million in April-June 2023.
For the year ended March 2023, ASTER DM HEALTHCARE reported 20.9% decrease in net profit to Rs 4,755 million compared to net profit of Rs 6,011 million during FY22. Revenue of the company grew 16.4% to Rs 119,329 million during FY23.
The current Price to earnings ratio of ASTER DM HEALTHCARE, based on rolling 12 month earnings, stands at 54.9.
Equitymaster requests your view! Post a comment on "ASTER DM HEALTHCARE Gains 7%; BSE HEALTHCARE Index Up 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!